In summary, our results reveal a novel regulatory signaling axis, PEPT1/MAP4K4/G3BP2, which is critical for inducing tumor metastasis in HCC, and provide a promising therapeutic target and prognostic indicator for patients with metastatic HCC. This evidence concerns the gene G3BP2 and hepatocellular carcinoma.